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ABSTRACT
Purpose Free of charge physiotherapy (FCP) is free 
physiotherapy provided by the Danish government for 
patients with a range of chronic diseases. To date, the 
population has not been described in depth making 
evaluation and decision making difficult. The purpose 
of this study was to (1) describe the development and 
the content of a novel clinical physiotherapy database 
for FCP (PhysDB- FCP) and (2) present the cohort profile 
based on the data collected.
Participants Ninety- nine clinics (17 460 FCP patients) 
were invited to participate in the development process 
from 2018 to 2019. Eleven clinics consented (2780 FCP 
patients) and 534 patients performed the physiotherapy 
assessment using the PhysDB- FCP tool, with 393/534 
completing the patient survey.
Findings to date The content of the PhysDB- FCP 
was developed through an iterative process involving 
consensus between clinical and research workgroups. 
Prior to using the tool all consenting sites received 
training to use/administer the tool. All data were 
collected/stored using the PhysDB- FCP. Items finally 
chosen for the PhysDB- FCP included demographic 
information, questions about health status and daily 
functioning, functional tests, treatment plan and 
validated questionnaires. The initial patient cohort 
composed of 63.4% women with main diagnoses of 
multiple sclerosis (22.7%) and Parkinson’s disease 
(17.0%). The ability to perform personal/instrumental 
activities of daily living and functional ability varied 
widely. Other non- physiotherapy related issues were 
identified in numerous patients (ie, 34.9% of patients 
were at risk of depression) and multidisciplinary 
interventional approaches could be considered.
Future plans The current study has provided a 
comprehensive description of patients receiving FCP, 
using data collected from the novel PhysDB- FCP. 
Collected information can be used to facilitate microlevel 
to macrolevel programme evaluation and decisions. 
Although the PhysDB- FCP is promising, the tool requires 
optimisation before it is implemented regionally and/or 
nationally.
INTRODUCTION
Chronic disease covers a wide range of 
diagnoses and age groups with different 
functional ability, clinical course and prog-
nosis. With an increased life expectancy 
the incidence and cost of chronic disease is 
becoming greater.1 As such, changes in policy 
and governmental interventions at different 
levels may be required. Worldwide, people 
with chronic disease have more life- affected 
years and will require more frequent support 
for activities of daily living (ADL) and societal 
participation.2 Clinical research in chronic 
disease has demonstrated that exercise 
improves the ability to perform ADL3 regard-
less of condition. Further, regular exercise 
Strengths and limitations of this study
 ► We implemented and piloted a generic physiother-
apy assessment tool and data collection/storage 
platform for patients receiving free of charge phys-
iotherapy in a region of Denmark.
 ► Clinical and research staff were consulted in the 
development of the tool, however a variety of front-
line clinicians were not consulted which may have 
reduced recruitment and compliance to items in the 
tool.
 ► Only 11/99 invited clinics partook in the study, how-
ever, clinics were broadly representative in terms 
of the size of the practice and size of the town/city 
served.
 ► 393/534 patients that received a physiotherapy 
assessment completed a patient survey about ed-
ucation, employment, general health, as well as the 
EQ- 5D, WHODAS 2.0 and WHO-5 questionnaires.
 ► This cohort may be limited by the low rate of adher-
ence at especially at follow- up which may be due to 
the generic assessment tool that may have been too 
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can reduce the risk of further complications and comor-
bidities associated with chronic disease.4 5 The long- term 
effects of exercise and treatment may also be influenced 
by individual psychological and social factors, such as 
motivation and self- efficacy. Lack of compliance when 
participating in exercise programmes has been linked to 
lower motivation and self- efficacy among patients with 
chronic disease.6 Therefore, providing active continuous 
support in exercise programmes for people with chronic 
disease, and addressing psychological and social factors, 
may improve compliance and health outcomes.
In Denmark, patients with chronic disease are often 
managed by primary care physiotherapists. Denmark has 
a state financed healthcare system, which provides free 
primary care services to people with health problems. 
One of these services is free of charge physiotherapy 
(FCP), which provides ongoing care to people with 
chronic disease (who fulfil strict disability criteria). FCP is 
primarily performed by private practice physiotherapists, 
and referred by general practitioners. In 2016, private 
practice physiotherapists provided FCP to more than 
67 000 patients including 43 different chronic disease 
categories.7 Depending on the disease severity and stage, 
the purpose of FCP is to either (1) increase function, (2) 
maintain function or (3) delay/slow the loss of function.8 
Patients in the programme are classified into one of two 
groups, entitled to different treatment depending on 
their level of disability; (1) patients with severe disability 
(defined as ‘a person who cannot manage indoors for 
24 hours without help or aids for daily personal life’) who 
may receive both individual (home- based or clinic- based) 
therapy and group therapy (clinic- based) or (2) patients 
with less severe disability (defined as ‘an abnormal func-
tion of the sensor- motoric or nervous- system’), which 
includes patients with a progressive diagnosis (such as 
newly diagnosed multiple sclerosis) who receive only 
group therapy.
Currently, physiotherapists treating patients in the FCP 
programme are only required to report the type and 
amount of treatment provided. Providing more compre-
hensive data (ie, data from the initial subjective assess-
ment, results of objective assessment and through patient 
surveys) would be useful and provide information on the 
types of patients, severity of illness and treatment strate-
gies implemented. As this information/ata are currently 
not reported centrally, it is difficult to evaluate the FCP 
programme. For private clinical practice, municipalities, 
organisational positions and the Danish health authori-
ties to make informed decisions on the FCP programme, 
systematic reporting is required, including more details 
about the patients receiving the service and how these 
patients are managed.
In 2015, funding was allocated to the development and 
implementation of a standardised tool to collect and store 
comprehensive and systematic data of patients treated in 
primary care receiving physiotherapy database for FCP 
in Denmark (PhysDB- FCP). The PhysDB- FCP provides 
an up- to- date description of the population receiving 
FCP including functional status, psychosocial status, goal 
setting, interventional aims and follow- up evaluation. In 
addition, the PhysDB- FCP has the potential to facilitate 
research, guide future decisions/directions, optimise 
patient care and ensure continued efficacy/efficiency of 
the FCP programme.
The current cohort profile aims to (1) describe the 
development and the content of the clinical database 
PhysDB- FCP and, (2) present the cohort profile based on 
data collected using the PhysDB- FCP tool. In addition, we 
will outline the potential uses and discuss possible future 
directions of the PhysDB- FCP.
STUDY DESIGN
The current study is a descriptive study of the develop-
ment and implementation of a novel research database of 
patients with chronic disease receiving FCP and provides 
a cohort profile of the preliminary data.
DATABASE DEVELOPMENT
Purpose of the PhysDB-FCP
The purpose of the PhysDB- FCP project is to (1) provide 
an easy to use digital, online, structured and standardised 
psychosocial and functional testing tool to guide initial 
clinical assessments, follow- up assessments and document 
progress of patients receiving FCP, (2) assist in the effi-
cient collection of comprehensive assessment data, (3) 
store data that is accessible, updated automatically and 
can be easily exported to enable evaluation and decision 
making of the FCP programme and (4) facilitate the use 
of a common language using International Classification 
of Functioning (ICF) terms.9
Patient and public involvement
The PhysDB is intended as a tool for physiotherapists 
to guide and structure their clinical assessment along 
with the purpose of collecting research data. As such, 
clinicians and researchers were used and influenced the 
development of the initial tool. However, the PhysDB was 
continuously tested on patients during this phase and 
adapted to increase its relevance to individual patient 
groups. Furthermore, as we have completed the initial 
development phase, and used the PhysDB in a range of 
patients, we are now able to consult patients to further 
optimise the tool for a wide range of patients. Within 
this, we will perform focus group discussions and semi- 
structured interviews with patients (and therapists) to 
further improve the tool and provide guidance/consider-
ations on all aspects of the tool.
PhysDB-FCP development
The PhysDB was established in 2008 to provide a digital 
online database to collect data on patients with only 
musculoskeletal problems. In 2015, a new project for 
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was supported by funding from the Danish Physiotherapy 
Research and Practice fund.
The PhysDB- FCP project was initiated by six clinical 
physiotherapists. These physiotherapists formed a clin-
ical workgroup that met six times between 2015 and 
2016. The clinical workgroup consisted of physiothera-
pists, each with >10 years’ experience in treating patients 
with chronic disease using the FCP service. The physio-
therapist in charge of the project (NBA, with >30 years’ 
experience) also met with a research workgroup eight 
times between 2015 and 2017. The research workgroup 
consisted of one researcher with expertise in rehabilita-
tion (Defactum, Region Midtjylland), two researchers 
with expertise in occupational rehabilitation, patient 
reported outcomes and epidemiology (Occupational 
Medicine, Danish Ramazzini Centre, Regional Hospital 
West Jutland) and one researcher with expertise in 
neurology and rehabilitation (Hammel Neurorehabilita-
tion Centre and University Research Clinic). The assess-
ment was continuously trialled by the clinical workgroup 
using patients receiving FCP to get feedback on its feasi-
bility and relevance. Consensus on the content of the data 
collection tool and PhysDB- FCP was an iterative process 
and reached through ongoing discussions with the clin-
ical and research workgroups. The overall purpose of 
the discussions was to develop a tool that offers clinically 
meaningful information with outcomes that could facili-
tate better patient care and research.
In August 2017, the data collection tool and PhysDB- FCP 
were finalised and pilot data collection commenced.
PhysDB-FCP procedure and content
The PhysDB- FCP provides an online standalone platform 
for collection and storage of both patient and clinician 
reported data from a survey provided to the patient and 
data collected from subjective and objective physiotherapy 
assessment performed by the physiotherapist, guided by 
a proforma from the PhysDB- FCP team. According to 
the regional ethics commission the study did not require 
ethical approval but required approval from the Data 
Protection Agencies.
Informed consent was obtained from patients prior to 
enrolment in the project. The procedure was as follows. 
First, referral to the physiotherapist was performed by 
the GP. Second, the patient contacted the physiotherapy 
clinic and talked to a health secretary or physiotherapist 
who provided information about the project. Third, the 
patient was provided a digital identifier and consented 
digitally. After informed consent, the secretary registered 
the patient, including the referral diagnosis attained 
from the GP.
Patients were asked to complete an online survey prior 
to the initial physiotherapy assessment. The survey was 
also administered prior to 3- month and 6- month assess-
ments. See figure 1 for an overview.
The data collected from the patient survey and the 
subjective and objective physiotherapy assessment 
consisted of demographic information, questions about 
health status and daily functioning, functional tests, treat-
ment plan and validated questionnaires. Table 1 provides 
an overview of the individual variables and administered 
questionnaires.
Physiotherapy assessment
The structured patient history covered all areas of the ICF 
and was guided by the clinical working group’s knowledge 
of patients with chronic disease. The patient history took 
approximately 20–30 min to complete.
Functional performance tests were selected based 
the ability of the tests to track basic mobility and func-
tioning in ADL’s, in patients with a range of diagnoses. 
Functional tests were also selected based on the time to 
administer, as the total assessment should be performed 
in <30 min. The chosen tests for the lower extremities 
were: (1) timed up and go (TUG) (2) 30 s sit stand test 
(SST) and (3) Walking test (either 10 m, 40 m or 6 min 
walk test). For the upper extremity the box and block test 
was performed. These tests are valid and reliable for a 
wide range of patients.10–17
The overall treatment plan was based on the domains 
of ICF framework. As such, specific management of 
impairments, activity limitations and participation 
restrictions were addressed. This part was developed 
with input from the clinical and research working 
groups.
In addition, when using the PhysDB, a written journal 
is automatically generated containing statements and 
results from the patient surveys, all parts of the assess-
ment and clinician comments.
Figure 1 The process and timing of patient recruitment, 
performance of functional tests and administration/
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Optional items in the physiotherapy assessment
Due to the diversity of diagnoses included in the 
PhysDB- FCP, more individualised optional assessments 
were required for some patients. Optional functional tests 
included: (1) functional analysis and postural control 
(Note: This was used for severely disabled patients who 
met certain inclusion criteria.), (2) Berg balance scale, 
(3) arm flexion test, (4) accelerometry to monitor daily 
activity, (5) full neurological examination, (6) range 
of motion and strength assessment, (7) Mini- Mental 
Stata Examination (MMSE) (cognitive assessment), (8) 
Tandem stance test, (9) Aastrand’s 1 point test.
Patient questionnaires
The patient surveys asked general information from the 
patient and included validated questionnaires. Informa-
tion gathered using the patent survey included civil status, 
education, works status, sick days (for those working), 
fear of falling and sleep quality (table 1, online supple-
mental table S1).
A separate process was used to find generic vali-
dated patient questionnaires to collect data based on 
the ICF domains and psychosocial factors. This process 
was performed by the Occupational Medicine, Danish 
Ramazzini Centre. The internal report recommended 
three tools for the PhysDB- FCP; EQ5D, WODAS 2.0 and 
WHO5.12
The EQ- 5D (EuroQol) was chosen to measure health- 
related quality of life. The EQ- 5D allows the assessment 
of the effect of a treatment at the impairment and activity 
level. It is also a valid and reliable assessment tool for a 
range of diagnoses.13
The WHODAS 2.0 (12 items) was chosen to measure 
the ICF domains in patients. Although other generic 
health status instruments can also be transferred to the 
ICF, these do not clearly distinguish between patient 
reported (subjective) measures of impairment, activity 
limitations and participation restrictions. Furthermore, it 
assesses disability and is used worldwide. As such, using 
this tool can facilitate comparisons between countries.14
The WHO-5 was chosen to assess mental well- being. It is 
a five- item questionnaire which assesses patient reported 
mental health in the preceding 2 weeks. The WHO-5 has 
been tested in various populations and in several coun-
tries.15 The tool is easy to apply, valid and reliable.15
Modifications
During data collection, the patient survey and clinical 
assessment were modified as some important questions 
were excluded initially. Through the pilot phase, although 
no questions/items were removed, some questions/items 
were added. Items added to the patient survey were the 
items; smoker, alcohol intake amount, physical load at 
work (if working), physical load during leisure time activ-
ities, self- perceived rating of physical fitness and desire to 
be more active. Items added to the physiotherapy assess-
ment included the; modified Rankin scale score, types of 
leisure activities, presence of comorbidities and type of 
comorbidities (using an adapted list from Charleston’s 
comorbidity index) and frequency of falls within the last 
month. Most items have been added to ensure the data 
will be comparable to other databases, and to assist in the 
description of general patient health and functioning. 
Due to the late implementation of these tools, data are 
incomplete and have not been reported.
COHORT DESCRIPTION
Participating clinics
Private outpatient clinics that provide FCP in the Region 
of Mid Jutland in Denmark (n=99 clinics) were invited to 
participate from August 2017 to January 2019. Figure 2 
shows the total number of patients receiving FCP asso-
ciated with the invited clinics. Clinics were contacted via 
email by the PhysDB- FCP implementation staff and invited 
to participate in the pilot study. The email provided 
Table 1 Information gathered and items contained in the physiotherapy assessment and patent survey
Physiotherapy 
assessment
Demographic information: name, age, sex, assessment date, year of diagnosis
Health status: pain (location and numeric rating), medication, height and mass (body mass index), 
involuntary weight loss and speaking/swallowing problems
Daily functioning: information about personal activities of daily living and instrumental activities of 
daily living, use of and type of assistive device(s), dizziness and fatigue
Obligatory functional tests
Timed up and go test, sit to stand test, walk test (choice of: 6 min, 40 m or 10 m walk test), Box and 
block test (if the patient has arm disability)
overall treatment plan: goal setting, overall treatment type (individual, team based, supervised or 
combined), expected time of treatment, expected effect of treatment (solving problem, reducing 
problem or delaying disease progression), patient acceptance of treatment plan planned retest 
assessment and disclosure to general practitioner (Y/N)
Patient surveys Individual questions
Civil status, education, work status, number of whole/half days of sick leave (for those working), fear 
of falling and sleep quality
Validated questionnaires
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information about the research project including the 
purpose of the assessment tool and the potential useful-
ness for both clinicians and researchers. If a clinic did 
not reply within 4 weeks, a follow- up email was sent. If a 
clinic still did not reply, no further contact was made. In 
total, 11 private outpatient clinics agreed to participate in 
the pilot phase (figure 2). Following clinic agreement, a 
member of the PhysDB- FCP implementation staff visited 
the site to discuss implementation and expectations. 
During the visit, physiotherapists were provided a 3- hour 
training session on how to administer the tool and use 
the PhysDB- FCP software. After an introduction to the 
PhysDB- FCP, physiotherapists began enrolling patients. 
Clinics were advised to contact the PhysDB- FCP imple-
mentation group if there were any questions/trouble-
shooting issues.
Participants
Patients that attended the participating clinics were 
invited to be assessed with the PhysDB- FCP data collection 
tool. Inclusion criteria were: (1) ≥18 years old, (2) chronic 
disease and an approved referral for FCP from a general 
practitioner and (3) being able to transport herself/
himself to and from the outpatient clinic.
Statistics
Descriptive statistics were used to describe baseline 
characteristics of the cohort. PhysDB- FCP. The number 
of patients and corresponding percentage (of the total 
sample) has been reported for all demographic and 
diagnostic information, health status variables, daily 
functioning and functional tests. Data management is 
performed using STATA V.15. No statistical comparisons 
have been made as data are used to describe the frame-
work to facilitate discussion on future perspectives of the 
database.
COHORT CHARACTERISTICS
In total, the 11 clinics provide consultations to 2780 
patients receiving FCP (figure 2). Over the period of the 
study, 534 FCP patients were assessed by a physiothera-
pist using the PhysDB- FCP tool and 393 of these patients 
completed the patient survey (figure 2). At 3 months, 
142 patients were assessed by a physiotherapist and 179 
patients answered the patient survey and at 6 months, 
52 patients were assessed by a physiotherapist and 166 
answered the patient survey.
The 11 clinics that volunteered represented small and 
large cities and similar to the 88 clinics not participating. 
Likewise, the number of physiotherapists working at the 
clinics ranged from 3 to 9 and was generally represen-
tative of the other 88 clinics however, very large clinics 
(>10 physiotherapists) were not represented in our study 
(online supplemental table S2).
Characteristics PhysDB-FCP
Demographics and characteristics of the patients assessed 
are reported in table 2. The majority of patients in the 
FCP programme were women (63.9%), the number of 
patients increased with age and more patients were cate-
gorised as having severe disability (68.4%) rather than 
less severe disability (30.5%). Primary diagnoses were 
multiple sclerosis, Parkinson’s disease, stroke and chronic 
arthritis (table 2). The breakdown of the ‘other’ diag-
noses are presented in online supplemental table S3.
Functional ability and activities of daily living: clinical 
assessment
Data collected by physiotherapists on functional ability 
and ADL are reported in tables 3 and 4. Additional data 
are reported in online supplemental table S4.
Table 3 provides information on the functional 
ability of patients. A large percentage of patients did 
not perform/were unable to perform the functional 
tests (TUG (31.1%), 30 s STS test (25.7%) and patients 
performing at least one walking test (34.6%)). Some 
patients (7.9%) required modifications to complete the 
Figure 2 Flow chart showing the number of invited clinics, 
the number of clinics that volunteered, with associated 
number of free of charge physiotherapy (FCP) patients. Also 
included are the number of patients that were assessed by 
a physiotherapist using the physiotherapy database for FCP 
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STS (ie, lowered seat height, assistive devices) however 
the type of modification wasn’t routinely collected. 
Most patients (94.9%) did not perform the box and 
block test.
Table 4 reports the type and amount of personal assis-
tance required for patients to perform ADL. Assistance 
with PADL’s was required by 26.4% of patients. When help 
with PADLs was required, this was most often provided by 
a partner. Assistance with IADL’s was required by 47.8% of 
patients, with 31.1% requiring help with ≥2 IADL’s. Assis-
tive devices were required by 58.1% of patients (table 4) 
with 32.8% of patients requiring ≥2 assistive devices 
(online supplemental table S4). The types and number 
of assistive device(s) used are described in online supple-
mental table S4.
Functional ability and activities of daily living: surveys
A total of 393/534 patients attempted the surveys. The 
results from the patient surveys are shown in online 
supplemental table S4. The majority of patients were on 
a pension/retired (51.9%) or employed with or without 
special arrangements (23.6%), lived in a house (60%) 
or apartment (23.4%), with 70.4% living with another 
person and 25.2% living alone. 375/393 patients (95.4%) 
completed the EQ- 5D- 5L and 320/393 patients (81.4%) 
completed the WHODAS 2.0 and WHO-5.
Table 2 Demographic and basic medical information 
gathered by the physiotherapy assessment and patient 
surveys




  Female 341 (63.9)
  Male 193 (36.1)
Age (years)
  18–29 24 (4.5)
  30–39 35 (6.6)
  40–49 75 (14.0)
  50–59 90 (16.8)
  60–69 139 (26.0)
  70–79 144 (27.0)
  80+ 27 (5.1)
Diagnosis
  Multiple sclerosis (and other demyelinating 
diseases)
121 (22.7)
  Parkinson’s disease (and other diseases of the 
basal ganglia)
91 (17.0)
  Stroke (ischaemic and haemorragic) 51 (9.6)
  Chronic arthritis (ie, rheumatoid arthritis) 46 (8.6)
  Other 208 (39.0)
  Missing 17 (3.2)
Type of treatment
  One- on- one treatment (more severe) 365 (68.4)
  Group therapy (less severe) 163 (30.5)
  Missing 6 (1.1)
Years with the condition
  0–4 125 (23.4)
  5–9 109 (20.4)
  10–14 65 (12.2)
  15–19 57 (10.7)
  20+ 137 (25.7)
  Missing 15 (2.8)
See online supplemental material for further breakdown.







  Not performed/unable to perform 166 (31.1)
  Performed 368 (68.9)
  Time (s) (n=368)
   <4.99 39 (10.6)
   5–9.99 217 (59.0)
   10–19.99 82 (22.3)
   20–29.99 19 (5.2)
   >30 10 (1.9)
STS in 30 s
  Not performed/unable to perform 137 (25.7)
  Performed with modifications 42 (7.9)
  Performed without modifications 355 (66.5)
  Number of STS (n=397)
   1–3 6 (1.5)
   4–6 40 (10.1)
   7–9 89 (22.4)
   10–12 119 (30.0)
   13+ 143 (36.0)
Walking tests
  Not performed/unable to perform 185 (34.6)
  Performed one test 348 (65.2)
  Performed two tests 1 (0.2)
   10MWT 99 (18.5)
   40MWT 138 (26.8)
   6MWT 113 (21.2)
Box and block test
  Not performed 507 (94.9)
  Performed 27 (5.1)
6MWT, 6 m walk test; 10MWT, 10 m walk test; 40MWT, 40 m walk 
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For the EQ- 5D- 5L (figure 3), only 8/375 participants 
reported no problems in all five domains. The level of 
problems for patients varied with the domain. The 
majority of patients had no problems with self care 
(60.5%) and anxiety/depresison (63.5%) however for 
mobility, usual activities and self- care only 24.3%, 20.3% 
and 13.9% reported no problems, respectively.
For the WHODAS 2.0 (figure 4), no patients reported 
‘no difficulty’ in all 12 domains. Most patients had at least 
some issues with emotional affect due to their condition 
(83.4%), standing for long periods (79%), walking a long 
distance (75.2%) and household responsibilities (73.9%). 
Patients had least issues with washing their whole body 
(35.0%), dealing with people they do not know (social, 
37.6%), maintaining friendships (40.0%) and concen-
trating on something for 10 min (42.9%).
The WHO-5 results are shown in figure 5. Scores were 
converted into a total score /25,15 and expressed as a 
percentage, with 0% representing worst imaginable well- 
being and 100% representing best imaginable well- being. 
For the purpose of the current study, patients at high- risk, 
moderate- risk and low- risk of depression was defined by 
scores ranging from 0% to 28%, 29% to 50% and >50%, 
respectively.15 The percentage of patients at high- risk, 
moderate- risk and low- risk of depression were 12%, 
22.9% and 65.1%, respectively.
FINDINGS TO DATE
This study describes the pilot process for the Danish physio-
therapy database for patients receiving FCP (PhysDB- FCP). 
The intention of the PhysDB- FCP is to create an easy to 
use assessment tool to record, monitor, assess and reassess 
patients with chronic disease receiving FCP. This study 
has described the development process, the content of 
the assessment tools and the cohort characteristics. We 
have illustrated that it is possible to provide a detailed 
Table 4 Assistance required when completing activities 




Assistance with PADL’s from another person
  No 358 (67.0)
  Missing 29 (5.4)
  Yes 147 (26.4)
  Help type*   
   Help from partner 87 (16.3)
   Services from municipality staff 32 (6.0)
   Services from other health professionals 22 (4.1)
   Other 30 (5.6)
  Help amount   
   Assistance from one source 125 (23.4)
   Assistance from two sources 20 (3.7)
   Assistance from three or more sources 2 (0.4)
Assistance with IADL’s from another person
  No 231 (43.3)
  Missing 48 (9.0)
  Yes 255 (47.8)
  Help type†   
   Help with shopping 127 (23.8)
   Help with cooking 121 (22.7)
   Help with cleaning 203 (38.0)
   Help with home- based activities 91 (17.0)
   Help with transportation 102 (19.1)
   Other help 23 (4.3)
  Help amount   
   1 IADL 89 (16.7)
   2 IADLs 45 (8.4)
   3 IADLs 43 (8.1)
   4 IADLs 33 (6.2)
   ≥5 IADLs 45 (8.4)
Use of assistive devices during daily living
  No 162 (30.3)
  Missing 62 (11.6)
  Yes‡ 310 (58.1)
*Some patients receive help from more than one source and 
total percentage will be greater than 100%.
†Some patients receive help for more than one activity and 
total percentage will be greater than 100%.
‡See online supplemental material for further breakdown.
IADL, instrumental activities of daily living; PADL, personal 
activities of daily living.
Figure 3 Summary results for the EQ- 5D- 5L questionnaire 
results. The percentage of patients at each problem level 
for each domain is shown in the horizontal bars (range 0%–
100%). The level of the problem was graded from no problem 
(none, lightest shade of grey) to extreme problems/unable to 
perform (Ext/unable, black). Domains measured by the EQ- 
ED- 5L were amount of anxiety/depression (Anx/Dep), amount 
of pain/discomfort (Pain/Disc), difficulty performing usual 
activities (Usual Act), difficulty washing or dressing (Selfcare) 
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description of these patients. Such a description has not 
been performed previously for patients with chronic disease 
receiving FCP, and as such, the PhysDB- FCP provides the 
possibility for future research investigating long- term inter-
ventions in patients with chronic disease. Despite this, the 
initial data also indicate that the PhysDB- FCP and associ-
ated assessment and survey, require further development.
Content of the PhysDB-FCP and comparisons with other 
databases
The PhysDB- FCP has the potential to provide exten-
sive data on patients receiving FCP. Nationally, similar 
registries have been created for specific diagnosis groups 
such as the Danish stroke registry (for patients with acute 
stroke16) and the Danish Head Trauma Database (for 
patients with severe traumatic brain injury17) and data-
bases specific to inpatient hospital care (such as those 
used in18–20). Internationally, databases have been imple-
mented in areas of primary care (such as the FYSIOPRIM 
Trondheim21), patient reported outcomes measurements 
in musculoskeletal care (Dutch physical therapy quality 
programme22), physical therapy outcomes registry for 
patient of diverse diagnoses, impairments and activity 
limitations23 and musculoskeletal health including the 
National Information Service for Allied Healthcare 
(in the Netherlands), Maccabi Healthcare Services (in 
Israel) and Focus On Therapeutic Outcomes (in the 
USA).24 National databases are important and have been 
instrumental in providing guidance to policy makers 
to continually improve practice. These can also deter-
mine and compare practices in different rehabilitation 
settings and provide an indication of the success/fail-
ures of a healthcare system. These databases are often 
specific to a diagnosis or population type and very rarely 
cater to multiple physiotherapy types (ie, musculoskel-
etal and neurological populations). Given this, although 
the framework for the implementation could be used as 
guidance, it was not possible to use these studies for guid-
ance on the actual content and assessments for a generic 
patient populations with multiple diagnoses and severi-
ties. Although databases often provide comprehensive 
Figure 4 Summary results for the WHODAS 2.0 
questionnaire results. The percentage of patients at each 
level for each domain is shown in the horizontal bars (range 
0%–100%). The level of difficulty was graded as the difficulty 
in performing each item in the past 30 days, from no difficulty 
(none, lightest shade of grey) to extreme difficulty/unable to 
do (Ext/unable, black). Domains measured by the WHODAS 
2.0 were the level of difficulty in standing for long periods 
(Standing), difficulty taking care of household responsibilities 
(Household), difficulty learning a new task (Learning), 
problems joining community activities (Activities), emotional 
affectedness by health problems (Emotion), difficulty 
concentrating (Concentration), difficulty walking a long 
distance (Walking), difficulty washing the body (Washing), 
difficulty getting dressed (Dressing), difficulty dealing with 
people (Social), difficulty maintaining friendship (Friendship) 
and difficult yin day- to- day work (Work/School).
Figure 5 Summary results for the WHO-5 questionnaire 
results. The percentage of patients at each problem level 
for each domain is shown in the horizontal bars (range 
0%–100%). The frequency of feelings in the past 2 weeks 
was graded from ‘All of the time’ (white) to ‘At no time’ 
(black). Domains measured by theWHO-5 were ‘Over the 
past few weeks …’; ‘I have felt cheerful and in good spirits’ 
(Cheerful), ‘I have felt calm and relaxed’ (Calm/Rel), ‘I have 
felt active and vigorous’ (Act/Vig), ‘I woke up feeling fresh and 
rested’(Fre/Rest) and ‘my daily life has been filled with things 
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general information about, they sometimes lack specific 
information related to ADL, specific functional scores and 
psychosocial measures. Prior to the allocation of funding 
to the PhysDB- FCP, there was a lack of clinical data on 
patients receiving outpatient physiotherapy for chronic 
conditions through the FCP scheme. With this database, 
we now have the ability to investigate detailed functional 
performance, ADL and other psychosocial factors directly 
related to long- term physiotherapy management. More-
over, we can assess the change in these factors in specific 
patient groups over time. These data may therefore have 
the potential to inform clinical and policy decisions.
General cohort characteristics
The PhysDB- FCP database provides a description of the 
initial cohort of people with chronic disease receiving 
FCP. This is the first time that this population has been 
described in Denmark, in terms of functional ability, ADL 
and psychosocial factors. The results indicate the diversity 
of patients within the FCP programme. More women than 
men were in the programme which broadly reflects the 
proportion of women and men within the main chronic 
disease categories.25–28 The four largest patient groups 
contained in the database were stroke, multiple scle-
rosis, Parkinson’s disease and chronic arthritis. Although 
patients of all ages were represented, more older patients 
were included, which is largely consistent with previous 
reports of age in patients with chronic disease (eg,29–32).
Unlike most databases, the PhysDB- FCP combines 
data from physiotherapy assessments and patient 
surveys. This combination in a large database provides 
unique opportunities to use data with a holistic view 
of the patient, that would normally not be collected or 
contained in databases. In general, the initial cohort 
showed higher physical functioning than expected. It 
was surprising how many patients required no help with 
PADL’s (67.0%) and IADL’s (43.3%). In addition, the 
functional ability of numerous patients was high with 
47.9% of patients performing TUG in <9.99 s and 49.0% 
of patients performing the 10+ STS in 30 s. Given this, 
a large percentage of patients receiving FCP were high 
functioning in terms of mobility, despite the majority 
(68.4%) being severely affected and eligible for one- 
on- one ongoing physiotherapy management. However, 
the surveys indicate that patients were struggling with 
other aspects of life, which were not captured by the phys-
iotherapy assessment. This highlights that patients have 
other issues and provides the basis for targeting aspects 
of patient care other than physical therapy. This holistic 
overview provides the opportunity to ensure appropriate 
management of the patient, as well as the potential to 
refer the patient to clinicians in more specialised areas, 
or different medical areas (ie, clinical psychology). For 
example, 34.9% of patients were at moderate- risk or 
severe- risk of depression. Such information is important 
to understand during a treatment session as for optimal 
outcomes related physiotherapy, these patients may need 
to be medicated or undergo specific therapy targeting 
depression. This type of information may have been 
missed with a standard physiotherapy assessment.
For higher functioning patients, it may be useful to track 
periods were the patient is able to attend group therapy, 
or perform self- management strategies, home exercise 
programmes33 and tele- rehabilitation.34 Appropriate use 
of the PhysDB- FCP could help inform decision making 
on these strategies along with guidance for appropriate 
treatment or referral, while also meeting future chal-
lenges of an increased population with chronic disease, 
without compromising patient care.
Difficulties encountered in design and implementation
There were several difficulties encountered during the 
design and implementation of the database. One main 
issue, is that we may not have developed a solid enough 
implementation framework for the design, implementa-
tion and piloting of the tool, a priori. A framework such 
as the implementation model proposed in Meerhoff et 
al,22 with the inclusion of implementation scientist in the 
project team, would have likely mitigated some of the 
difficulties we encountered (see later).
Due to the diversity of patients included in the 
PhysDB- FCP, and that there is currently no core outcome 
set for such a diverse group of patients, designing a tool 
that was generic enough to be relevant for all included 
diagnosis and multiple severities, was difficult. In an 
attempt to create a generic tool for all patients, the 
working group may have lost sight of the usability of 
the tool clinically. Although patients, clinicians and 
researchers were consulted in the design of the tool, and 
the questions within, it may have been beneficial to attain 
the views of multiple other stakeholders (ie, Implementa-
tion scientists and a wider variety of patients and frontline 
clinicians), outside of the core group. Such insights, prior 
to the implementation of the pilot process, may have 
improved the number of (1) sites included, (2) patients 
sampled at the sites, (3) patients followed up at 3 and 
6 months and (4) patients that completed the patient 
survey.
Clinicians did not complete all assessments, and within 
the data extraction form there was no place to provide 
feedback as to why the task was not selected. For example, 
of the 166 patients that did not perform the TUG test, 
83.7% of these patients did not perform a walking test. 
Although 34.9% were using a wheelchair in daily life, 
48.8% (83.7% minus 34.9%) could walk but didn’t 
perform the TUG. Given this, it was difficult to ascertain 
(1) if the task was too difficult for the patient (2) if the task 
was too easy for the patient (and the test was irrelevant) 
or (3) or for some other reason (ie, time constraint’s). 
Embedding the potential for feedback within the data 
collection tool, when tests weren’t performed would have 
provided a more comprehensive view of the function-
ality of the patient. Another assessment that was rarely 
performed was the box and block test. Although 26.4% 
of patients required assistance with PADLs (and the box 
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performed the test. From the current data collection plat-
form, we do not know why this occurred. It may have been 
that the physiotherapist lacked the skills to perform this 
test, they may have felt that it was irrelevant or some other 
reason.
Possible other reasons for low adherence could be (1) 
the PhysDB data collection tool and patient survey were 
too long and need to be shortened for some patients, 
(2) more individualised assessments based on diagnosis 
and severity should be implemented in the tool which 
would provide a better overview of specific patients, (3) 
difficulty in tool administration as it was not embedded 
in their normal software system meaning clinicians had 
to perform ‘double work’ (ie, using their own system 
and the PhysDB- FCP system), (4) follow- up assessments 
at 3 and 6 months were not always relevant for patients 
at the sampled time points because of the chronicity 
of their health conditions that do not always change as 
quickly over time and (5) the tool was not mandatory 
and participating physiotherapist could chose not to use 
the PhysDB- FCP if circumstances weren’t ideal for data 
collection.
To further expand on these hypotheses and elucidate 
processes and issues that may have caused low adherence, 
we are now designing a study to investigate the clinician 
and patient views of the PhysDB- FCP tool to formally 
document experiences of clinicians and patients and 
iterate the tool to ensure it is optimised for future use.
STRENGTHS AND LIMITATIONS
The PhysDB- FCP provides a comprehensive biopsycho-
social assessment of patients which may guide clinicians 
in daily patient care and provide the possibility to track 
patients over time. This allows for the platform to be used 
in quality improvement, larger interventional studies, 
prognostic modelling and provide information for 
national (between region) and international comparisons 
in healthcare, as has been done previously for musculo-
skeletal conditions.24 Further, data from PhysDB- FCP can 
be linked to other public registries in Denmark using the 
national CPR system to assist in changing and enhancing 
patient care and outcomes. Moreover, the tool provides 
an assessment guide and can automatically insert data 
into patient records. This may facilitate equal healthcare 
throughout the country, aid in the collection of essential 
generic information and reduce consultation time. The 
current study provides a glimpse of the potential of the 
PhysDB- FCP with preliminary description of the cohort 
providing the basis for conversations around the patient 
management in the FCP programme. Despite the advan-
tages of the PhysDB- FCP, the initial results indicate that 
there are some unsolved challenges.
Only 10% of the invited clinics chose to participate and 
therefore our sample may not be representative of all 
clinics in Denmark. Despite this, geographical placement 
and the number of small and large clinics did not differ 
substantially between participating and non- participating 
clinics (see online supplemental table S2). Adherence 
to the assessment and survey was lower than expected, 
at both baseline and follow- up, especially in a group of 
therapists that volunteered to be part of the programme, 
where higher adherence might be expected. Lower than 
expected adherence has also been observed in another 
study attempting to implement a similar database in 
musculoskeletal primary care physiotherapy.35 Adher-
ence/compliance data in the current study may actu-
ally reflect a ‘best case’ scenario and bias the results to 
a more favourable adherence/compliance rate. Given 
this, consideration must be given to the reasons thera-
pists may have been non- compliant. Possible reasons have 
been stated in the ‘difficulties encountered in design and 
implementation’ and include irrelevant assessments for 
many patients with a tool that is too long, sampling too 
frequently for chronic conditions, non- mandatory data 
collection form, ‘double entry’ of assessments in their 
standard assessment for and the PhysDB- FCP. Solutions 
to increase compliance/adherence could include (1) 
collecting assessment data yearly to reflect the clinical 
course and relevance in patients with chronic condi-
tions, (2) embedding the PhysDB- FCP platform with 
the current computer programmes used in the clinic to 
avoid double entry (3) using a shorter generic version 
and adding more disease specific items or questionnaires 
for certain patients that may increase meaningfulness of 
the tool for each patient. The next step will be to collect 
feedback and experiences from clinicians and patients to 
further improve the PhysDB- FCP tool and patient survey. 
In a future study, we will conduct surveys, semi- structured 
interviews and focus group discussions with therapists 
and patients involved in the project to further refine and 
develop the PhysDB- FCP assessment tool and patient 
survey. In this, we intend to describe the barriers and 
facilitators (including how these assessments should be 
altered) to optimise and refine the assessment forms and 
questions within. Following this, therapists and patients 
will be re- consulted to ensure the correct changes have 
been implemented. In the concurrent study, patients and 
therapists will be asked about the potential adaptions in 
attempt to increase adherence. Clinicians and patients 
will also be asked how to create a more patient- centred 
assessment form.
CONCLUSION
The current study has provided a description of the devel-
opment and content of the PhysDB- FCP tool for chronic 
patients using the FCP programme. Within this process 
we have collected data on an initial cohort using the tool 
and demonstrated that it is possible to provide a compre-
hensive cohort profile using data collected from the 
physiotherapist and patient. Although, the PhsyDB- FCP 
is promising, further research into the PhysDB- FCP is 
required to optimise the physiotherapy assessment and 
survey questions and to understand the barriers and facil-
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and patient) perspective. If these steps are taken and the 
PhysDB- FCP is implemented regionally or nationally, such 
data would be useful for describing the types of patients 
within the FCP programme and can be used to optimise 
the FCP programme. In turn, decisions can be made to 
optimise patient care.
COLLABORATION
Data available includes the data described within the text 
and online supplemental material. If research groups 
have a question they would like to answer using these 
data, they should apply to Nils- Bo de Vos Andersen with 
a brief (one page) project proposal. If the project is 
deemed potentially suitable (ie, a similar proposal is not 
already being considered and the project is within scope), 
meeting(s) will be scheduled with members of the project 
team to discuss the protocol in more detail. Following 
this, documents will need to be prepared by the research 
group proposing the project. This will include, (1) ethical 
approval from the home institution, (2) data sharing 
agreement with the Danish Data protection agency, (3) 
data sharing agreement with the EU. Approval processes 
can take up to 1 year. If data linkage with other registries 
is required, further approvals will be required extending 
the likely timeframe. In all circumstances, data released 
will be anonymous.
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